APA (7th ed.) Citation

Ilaria Galgani, Airi Põder, Rain Jõgi, Veli-Jukka Anttila, Stefano Milleri, Alberto M. Borobia, . . . Ashwani K. Arora. (2023). Immunogenicity and safety of the non-typable Haemophilus influenzae-Moraxella catarrhalis (NTHi-Mcat) vaccine administered following the recombinant zoster vaccine versus administration alone: Results from a randomized, phase 2a, non-inferiority trial. Taylor & Francis Group.

Chicago Style (17th ed.) Citation

Ilaria Galgani, et al. Immunogenicity and Safety of the Non-typable Haemophilus Influenzae-Moraxella Catarrhalis (NTHi-Mcat) Vaccine Administered Following the Recombinant Zoster Vaccine Versus Administration Alone: Results from a Randomized, Phase 2a, Non-inferiority Trial. Taylor & Francis Group, 2023.

MLA (9th ed.) Citation

Ilaria Galgani, et al. Immunogenicity and Safety of the Non-typable Haemophilus Influenzae-Moraxella Catarrhalis (NTHi-Mcat) Vaccine Administered Following the Recombinant Zoster Vaccine Versus Administration Alone: Results from a Randomized, Phase 2a, Non-inferiority Trial. Taylor & Francis Group, 2023.